sunitinib
Ligand Summary
An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.
UNII: V99T50803M
PubChem: 5329102
PubChem: 6456015
Guide to Pharmacology: 5713
ChEMBL: CHEMBL535
ChEMBL: CHEMBL1567
DrugCentral: 2544
LyCHI: T16444CNC2AA
Target Activities
297 Activities
Items per page:
10
1 – 10 of 297
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||